Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Beare

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|June 22, 2018
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trialAlison C Backen, Andre Lopes, Harpreet Wasan, et al.
The Lancet. Oncology|July 17, 2015
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trialJuan W Valle, Harpreet Wasan, Andre Lopes, et al.
JAMA|December 4, 2019
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical TrialPeter J Hoskin, Kirsten Hopkins, Vivek Misra, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Cancer|June 22, 2018
Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trialAlison C Backen, Andre Lopes, Harpreet Wasan, et al.
The Lancet. Oncology|July 17, 2015
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trialJuan W Valle, Harpreet Wasan, Andre Lopes, et al.
JAMA|December 4, 2019
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical TrialPeter J Hoskin, Kirsten Hopkins, Vivek Misra, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
Pageof 2